Cargando…
Retrospective Evaluation of Acute Kidney Injury After Zoledronic Acid Administration to Dogs With Malignant Osteolysis
Zoledronic acid (ZOL) is an intravenous bisphosphonate indicated for the use of hypercalcemia of malignancy and management of bony metastases. Its therapeutic effect lies in the targeting of malignant osteoclasts; however, administration can be associated with renal toxicity. The objective of this r...
Autores principales: | Vidal, Sarah A., Skorupski, Katherine A., Willcox, Jennifer L., Palm, Carrie A., Burton, Jenna H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282816/ https://www.ncbi.nlm.nih.gov/pubmed/34277751 http://dx.doi.org/10.3389/fvets.2021.647846 |
Ejemplares similares
-
Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study
por: Willcox, Jennifer Lindley, et al.
Publicado: (2020) -
Case report: Presumptive subcutaneous malignant peripheral nerve sheath tumor with intracranial invasion and osteolysis in the posterior fossa of a dog
por: Hidari, Kyosuke, et al.
Publicado: (2022) -
Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration
por: Nooh, Anas, et al.
Publicado: (2017) -
SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis
por: Gu, Minghui, et al.
Publicado: (2022) -
Toxicity of zoledronic acid after intravenous administration: A retrospective study of 95 dogs
por: Brewer, David John, et al.
Publicado: (2021)